Single Point Partners, LLC Novo Nordisk A S Transaction History

Single Point Partners, LLC

  • $426 Million
  • Q1 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023
SELL
$132.34 - $159.14 $9,131 - $10,980
-69 Reduced 3.0%
2,228 $355,000
Q4 2022

Jan 10, 2023
BUY
$102.55 - $135.33 $235,557 - $310,853
2,297 New
2,297 $311,000
Q2 2022

Jul 29, 2022
BUY
$103.24 - $121.81 $185,212 - $218,527
1,794 New
1,794 $200,000

Others Institutions Holding NVO

# of Institutions
1,861
Shares Held
336M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $135B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Single Point Partners, LLC Portfolio

Follow Single Point Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Single Point Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email